Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estetrol for hospitalized patients with moderate COVID-19
2020-003403-33Phase 2Completed
- Sponsor
- NEURALIS s.a.
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Estetrol with Placebo (2 arms). Primary endpoint: Recovery at Day 28. Started Dec 2020; status: completed.
02
Drugs
estetrol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-003403-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003403-33.